Levels of serum autoantibodies (aAb) to glutamate receptors and products of nitric oxide (NO) metabolism, i.e., nitrates and nitrites, were assayed in children with recent craniocerebral trauma (CCT) of different levels of severity. All the children showed increases in serum aAb to both AMPA and NMDA receptor subtypes from day 1 to day 10 after trauma. The highest levels of serum aAb were to the NMDA subtype of glutamate receptor, which was characteristic of children with mild CCT (MCCT), with Glasgow Coma Scale (GCS) scores of 14–15 points. Levels of aAb to NMDA (NR2A) receptors in children with severe CCT (SCCT, GCS < 9 points) were lower than in children with MCCT, the lowest levels being seen in the group of children with lethal CCT (SCCT-2). Serum concentrations of NO metabolites increased by large factors in the group of children with SCCT, indicating marked brain hypoxia.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
V. G. Bazarova, O. K. Granstrem, and S. A. Dambinova, “Levels of autoantibodies to glutamate receptor subunits and blood immunological measures in patients with epilepsy,” Vopr. Med. Khimii, 48, No. 4, 381–387 (2002).
I. V. Gannushkina, Immunological Aspects of Trauma and Vascular Brain Lesions [in Russian], Meditsina, Moscow (1974).
M. U. Gappoeva, Comparative Studies of the Expression and Immunoreactivity of NMDA Receptors in Extreme Cerebral Ischemia and Brain Hemorrhage [in Russian], Author’s Abstract of Master’s Thesis in Medical Sciences, Moscow (2003).
O. V. Globa, E. G. Sorokina N. Yu. Semenova, et al., “The paroxysmal activity test in pediatric neurology,” in: Advances in Functional Neurochemistry: Collected Reports [in Russian], St. Petersburg (2003), pp. 389–402.
A. V. Goronova, N. A. Bazarnaya, and E. G. Sorokina, “Dynamics of glutamate receptor autoantibody levels in children with chronic posttraumatic headache,” Zh. Nevrol. Psikhiat., 106, No. 8, 50–53 (2006).
S. A. Dambinova and G. A. Izykenova, “Autoantibodies to glutamate receptor subtypes as markers of functional brain lesions – their diagnostic significance for the detection of paroxysmal activity and ischemia,” Zh. Vyssh. Nerv. Deyat., 47, 439–446 (1997).
S. A. Dambinova, M. M. Odinak, D. I. Skulyabin, “Laboratory methods in epilepsy and brain circulatory lesions,” Zh. Nevrol. Psikhiat., 1, 58–64 (2001).
V. G. Pinelis, E. G. Sorokina,V. P. Reutov, et al., “Effects of the toxic action of glutamate and nitrite on cyclic GMP contents in neurons and their survival,” Dokl. Ros. Akad. Nauk, 352, No. 2, 259–261 (1997).
V. G. Pinelis, A. I. Yurvichus,V. P. Reutov, et al., “Effects of NO-generating compounds and glutamate on intracellular Ca2+ ion contents and the energy functions of mitochondria in neurons in the rat cerebellum,” in: Purines and Nitrogen Monoxide. Regulatory Functions in the Body [in Russian], Tekhnoprint, Minsk (2003), pp. 95–97.
A. B. Poletaev, “Paradoxes in immunoneurology,” in: “Neurochemistry: Basic and Applied Aspects. Conference Proceedings [in Russian], Moscow (2005).
V. P. Reutov, E. G. Sorokina,V. E. Okhotin, and N. S. Kositsyn, Cyclic Conversion of Nitric Oxide in Mammalian Bodies [in Russian], Nauka, Moscow (1998).
E. G. Sorokina, V. P. Reutov, V. G. Pinelis, et al., “Mechanisms of the potentiating actions of albumin in the toxic action of glutamate: a possible role for nitric oxide,” Biol. Membrany, 16, No. 3, 318–323 (1999).
E. G. Sorokina,V. P. Reutov, O. K. Granstrem, et al., “A possible role for nitric oxide in damage to glutamate receptors in epilepsy,” Vesti Nats. Akad. Nauk Belarusi. Ser. Med.-Biol. Nauk, 1, 18–22 (2002).
E. G. Sorokina, V. P. Reutov, O. K. Granstrem, et al., “Studies of the mechanisms of formation of autoantibodies in epilepsy and hypoxia,” Neiroimmunologiya, 1, No. 2, 137–138 (2003).
R. M. Khaitov, G. A. Ignat’eva, and I. G. Sidorovich, Immunology [in Russian], Meditsina, Moscow (2002).
J. J. Archelos and H.-P. Hartung, “Pathogenic role of autoantibodies in neurological diseases,” Trends Neurosci., 23, 317–327 (2000).
A. A. Boldyrev, V. I. Kazey, T. A. Leinsoo, et al., “Rodent lymphocytes express functionally active glutamate receptors,” Biochem. Biophys. Res. Commun., 324, 133–139 (2004).
D. W. Choi, “Glutamate neurotoxicity and diseases of the nervous system,” Neuron, 1, 623–624 (1998).
S. A. Dambinova, O. K. Granstrem, A. Tourov, et al., “Monitoring of brain spiking activity and autoantibodies to N-terminus domain of GluRl subunit of AMPA receptors in blood serum of rats with cobalt-induced epilepsy,” J. Neurochem., 5, 2088–2093 (1998).
S. A. Dambinova, G. A. Khounteev, G. I. Izykenova, et al., “Blood test detecting autoantibodies to N-methyl-D-aspartate neuroreceptors for evaluation of patients with transient ischemic attack and stroke,” Clin. Chem., 49, No. 10, 1752–1762 (2003).
M. J. During, C. W. Symes, P. A. Lawlor, et al., “An oral vaccine against NMDAR1 with efficacy in experimental stroke and epilepsy,” Science, 287, 1453–1460 (2000).
A. Lewen, P. Matz, and P. H. Chen, “Free radical pathways in CNS injury,” J. Neurotrauma, 17, 871–890 (2000).
Li Chung-Yu, Chin Tig-Yu, and S.-H. Chueh, “Rat cerebellar granule cells are protected from glutamate-induced excitotoxicity by S-nitrosoglutathione but not glutathione,” Amer. J. Physiol. Cell. Physiol., 286, 393–904 (2004).
S. A. Lipton, Y.-B. Choi, Zh.-H. Pan, et al., “A redox-based mechanism for the neuroprotective and neurodestructive effects of nitric oxide and related-compounds,” Nature, 364, 626–632 (1993).
W. G. Mayhan, “Nitric oxide donor-induced increase in permeability of the blood-brain barrier,” Brain Res., 866, 101–108 (2000).
G. Miglio, F. Varsaldi, and G. Lombardi, “Human T lymphocytes express N-methyl-D-aspartate receptors functionally active in controlling T cell activation,” Biochem. Biophys. Res. Commun., 338, No. 4, 1875–1883 (2005).
P. Pacher, J. S. Beckman, and L. Liaudet, “Nitric oxide and peroxynitrite in health and disease,” Physiol. Rev., 87, 315–424 (2007).
S. W. Rogers, P. i. Andrews, L. S. Gahring, et al., “Autoantibodies to glutamate receptor GluR3 in Rasmussen’s encephalitis,” Science, 265, 648–651 (1994).
B. C. White, J. M. Sullivan, D. J. DeGracia, et al., “Brain ischemia and reperfusion: molecular mechanisms of neuronal injury,” J. Neurol. Sci., 179, 1–33 (2000).
Author information
Authors and Affiliations
Additional information
Translated from Zhurnal Nevrologii i Psikhiatrii imeni S. S. Korsakova, Vol. 108, No. 3, pp. 67–72, March, 2008.
Rights and permissions
About this article
Cite this article
Sorokina, E.G., Semenova, Z.B., Bazarnaya, N.A. et al. Autoantibodies to Glutamate Receptors and Products of Nitric Oxide Metabolism in Serum in Children in the Acute Phase of Craniocerebral Trauma. Neurosci Behav Physi 39, 329–334 (2009). https://doi.org/10.1007/s11055-009-9147-1
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11055-009-9147-1